Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

Lots of vegetables, olive oil, nuts, whole grains, and occasional fish–these foods form the core of not only my diet but also ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...

The results from the two trials of early-stage Alzheimer's patients, called EVOKE and EVOKE+, are another setback for the ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main ​goal in late-stage trials ...

A new respite program for caregivers of Alzheimer's patients highlights the need for support for Vermont families battling ...

What is reminiscence therapy? It's the approach Chris Hemsworth is using to fight his father's Alzheimer's disease in his new ...

Early-onset dementia is linked to shorter survival, with the highest mortality risk in patients with frontotemporal dementia, ...